Back in the Spring, I was writing about the flurry of activity when the news of PHARMA’s exodus from CNS drug development hit, and I ran across a speech by British Neuropsychopharmacologist, Dr. David Nutt, at the Royal College of Psychiatry in June 2011 that antedated the more recent flurry of lamentations [No Psychiatry Without […]